Literature DB >> 11390626

Heparin inhibits retrovirus binding to fibronectin as well as retrovirus gene transfer on fibronectin fragments.

D Carstanjen1, P Dutt, T Moritz.   

Abstract

Fibronectin fragments have been shown to improve retrovirus gene transfer efficiency by binding retrovirus and target cells. Using a novel virus adhesion assay, we confirmed binding of type C oncoretrovirus vectors to the heparin II domain of fibronectin and demonstrated inhibition of viral binding and gene transfer by heparin.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11390626      PMCID： PMC114340          DOI： 10.1128/JVI.75.13.6218-6222.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  29 in total

Review 1.  Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction (Review).

Authors:  M A Dao; J A Nolta
Journal:  Int J Mol Med       Date:  1998-01       Impact factor: 4.101

2.  Proteoglycans secreted by packaging cell lines inhibit retrovirus infection.

Authors:  J M Le Doux; J R Morgan; R G Snow; M L Yarmush
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.

Authors:  T Moritz; V P Patel; D A Williams
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor.

Authors:  H P Kiem; R G Andrews; J Morris; L Peterson; S Heyward; J M Allen; J E Rasko; J Potter; A D Miller
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

5.  Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells.

Authors:  H Hanenberg; K Hashino; H Konishi; R A Hock; I Kato; D A Williams
Journal:  Hum Gene Ther       Date:  1997-12-10       Impact factor: 5.695

6.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.

Authors:  H Hanenberg; X L Xiao; D Dilloo; K Hashino; I Kato; D A Williams
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments.

Authors:  T Moritz; P Dutt; X Xiao; D Carstanjen; T Vik; H Hanenberg; D A Williams
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

8.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy.

Authors:  A Larochelle; J Vormoor; H Hanenberg; J C Wang; M Bhatia; T Lapidot; T Moritz; B Murdoch; X L Xiao; I Kato; D A Williams; J E Dick
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

9.  Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor.

Authors:  D Toksoz; K M Zsebo; K A Smith; S Hu; D Brankow; S V Suggs; F H Martin; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease.

Authors:  T Moritz; D C Keller; D A Williams
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307
View more
  6 in total

Review 1.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

2.  Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.

Authors:  Peter Ebeling; P Bach; U Sorg; A Schneider; T Trarbach; D Dilloo; H Hanenberg; S Niesert; S Seeber; T Moritz; M Flasshove
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-20       Impact factor: 4.553

3.  Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin.

Authors:  Pedro Lei; Bharat Bajaj; Stelios T Andreadis
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections.

Authors:  Christiane Beer; Lene Pedersen
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

5.  Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.

Authors:  M Cesani; T Plati; L Lorioli; F Benedicenti; D Redaelli; F Dionisio; L Biasco; E Montini; L Naldini; A Biffi
Journal:  Gene Ther       Date:  2015-03-12       Impact factor: 5.250

6.  Estimation of a stronger heparin binding locus in fibronectin domain III14 using thermodynamics and molecular dynamics.

Authors:  Sakshi Gupta; Neha Tiwari; Jyoti Verma; Mohd Waseem; Naidu Subbarao; Manoj Munde
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.